MKB Nedsense N.V.
MKB Nedsense N.V. engages in the financing and lending of funds to natural persons and legal entities. It provides guarantees and/or other securities to third parties for its obligations and/or for obligations for companies in its investment portfolio. The company was formerly known as Nedsense Enterprises N.V. amd changed its name to MKB Nedsense N.V. in February 2018. MKB Nedsense N.V. was foun… Read more
MKB Nedsense N.V. (0ML7) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, MKB Nedsense N.V. (0ML7) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
MKB Nedsense N.V. - Net Assets Trend (None–None)
This chart illustrates how MKB Nedsense N.V.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for MKB Nedsense N.V. (None–None)
The table below shows the annual net assets of MKB Nedsense N.V. from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to MKB Nedsense N.V.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
MKB Nedsense N.V. Competitors by Market Cap
The table below lists competitors of MKB Nedsense N.V. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
ACURX PHARMACEUT. DL-001
F:3ZO
|
$386.98K |
|
Elevai Labs, Inc. Common Stock
NASDAQ:ELAB
|
$387.31K |
|
CO.DON AG INH. O.N.
F:CNW
|
$387.77K |
|
Searchlight Resources Inc
PINK:SCLTF
|
$388.04K |
|
TRACTOR SUPPLY (TR4.SG)
STU:TR4
|
$386.81K |
|
KOMATSU
MU:KOM1
|
$386.74K |
|
Rasna Therapeutics Inc
PINK:RASP
|
$385.90K |
|
SNEP
BC:SNEP
|
$385.84K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in MKB Nedsense N.V.'s equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares MKB Nedsense N.V.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently MKB Nedsense N.V. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares MKB Nedsense N.V.'s net assets metrics with peer companies in the same industry.
Industry Context
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| MKB Nedsense N.V. (0ML7) | €- | N/A | N/A | $386.90K |
| Nyfosa AB (0A0K) | $2.92 Billion | 39.50% | 2.88x | $973.31 Million |
| High Templar Tech Limited (0A2T) | $12.52 Billion | 4.70% | 0.13x | $255.82 Million |
| Strategy Inc (0A7O) | $51.04 Billion | -7.54% | 0.21x | $40.17 Billion |
| NACON SASU (0A9N) | $67.54 Million | 15.85% | 1.20x | $7.64 Million |
| Antin Infrastructure Partners (0AA5) | $23.79 Million | 108.98% | 1.09x | $573.10 Million |
| Truecaller AB Series B (0AA7) | $1.41 Billion | 18.30% | 0.20x | $281.60 Million |
| Brockhaus Technologies AG (0AAW) | $254.92 Million | -6.23% | 1.68x | $74.40 Million |
| Hyloris Pharmaceuticals S.A. (0AB6) | $48.06 Million | -24.09% | 0.32x | $71.96 Million |
| Kalray S.A. (0ABT) | $28.43 Million | -41.56% | 0.67x | $33.84 Million |
| Webuild S.p.A. (0BJP) | $1.43 Billion | 10.29% | 7.14x | $1.13 Billion |